Lena Danielsson

Title: Lena Danielsson: Innovator in Monoclonal Antibody Production

Introduction

Lena Danielsson is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of biotechnology, particularly in the production of human monoclonal antibodies. Her innovative methods have the potential to advance medical research and therapeutic applications.

Latest Patents

Lena Danielsson holds a patent for a method of producing human monoclonal antibodies. This patent, which is titled "Method of producing human monoclonal antibodies and kit therefor," describes a technique for the removal of undesired cells from human lymphocyte-containing cell populations. The method utilizes lysosomotropic agents to act in vitro on these cell populations. Additionally, the patent outlines a process for the in vitro immunization of lymphocytes, which is crucial for producing human monoclonal antibodies. The kit associated with this method includes containers for lymphokines and lysosomotropic agents, facilitating the immunization process.

Career Highlights

Lena has established herself as a key figure in her field through her innovative research and development efforts. Her work at Bioinvent International AB has positioned her at the forefront of advancements in monoclonal antibody production. With her expertise, she has contributed to the understanding and application of immunological techniques in biotechnology.

Collaborations

Lena Danielsson collaborates with notable colleagues, including Susanna Moller and Carl A. Borrebaeck. These partnerships enhance her research capabilities and foster innovation within her projects.

Conclusion

Lena Danielsson's contributions to the field of biotechnology, particularly in the production of human monoclonal antibodies, highlight her role as an influential inventor. Her patented methods and collaborative efforts continue to drive advancements in medical research and therapeutic applications.